Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02467361 |
| Title | A Study of BBI608 Administered in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Cancers |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Boston Biomedical, Inc |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Colorado Cancer Center | Denver | Colorado | 80045 | United States | Details | |
| Emory University Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| University of Chicago Medicine Comprehensive Cancer Center | Chicago | Illinois | 60637 | United States | Details | |
| Massachusetts General Hospital Cancer Center | Boston | Massachusetts | 02114 | United States | Details | |
| Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
| Weill Cornell Medical College | New York | New York | 10065 | United States | Details | |
| Institute for Translational Oncology Research | Greenville | South Carolina | 29605 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |